Profile
CHEK DHR-PB TMO DHR IDXX A
Company Name Check-Cap Ltd. Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation IDEXX Laboratories, Inc. Agilent Technologies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap $9.83M $916.76B $203.95B $153.12B $51.47B $36.74B
Employees 0.09K 79.00K 125.00K 61.00K 11.00K 17.90K
CEO David Lontini Rainer M. Blair Marc N. Casper Rainer Blair Jonathan J. Mazelsky Padraig McDonnell
Ratings
CHEK DHR-PB TMO DHR IDXX A
Quant Rating Score 2 5 3 3 3 3
Quant Rating Sell Strong Buy Neutral Neutral Neutral Neutral
Trading
CHEK DHR-PB TMO DHR IDXX A
Last Close $1.86 $1261.26 $567.16 $220.44 $669 $144.52
High 52 $2.54 $1261.26 $606.74 $250.59 $722.94 $152.6
Low 52 $0.57 $1261.26 $390.2 $174.64 $361.04 $99.29
Price vs. 52 Week High -26.77 % 0 % -6.52 % -12.03 % -7.46 % -5.29 %
Price vs. 52 Week Low 226.32 % 0 % 45.35 % 26.23 % 85.3 % 45.55 %
Total Return
CHEK DHR-PB TMO DHR IDXX A
1 Month Return 2.2 % 0 % 5.24 % 5.44 % 5.29 % 1.83 %
3 Month Return 181.39 % 0 % 16.29 % 5.47 % 4.88 % 22.32 %
6 Month Return 101.06 % 0 % 37.64 % 12.41 % 29.13 % 27.03 %
9 Month Return 115.6 % 0 % 8.42 % 7.78 % 48.98 % 6.89 %
YTD Return 87.9 % 0 % 9.02 % -3.97 % 61.81 % 7.58 %
1 Year Return 144.7 % 0 % 11.4 % -4.51 % 60.69 % 14.98 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
CHEK DHR-PB TMO DHR IDXX A
Dividend Yield Percentage (TTM) - 0.59 % 0.32 % 0.59 % - 0.77 %
Dividend Paid and Capex Coverage Ration (TTM) - 3.15 % 3.62 % 3.15 % 9.48 % 2.26 %
Dividend Per Share (TTM) - 1.28 % 1.72 % 1.28 % - 1 %
Payout Ratio (TTM) - 24.29 % 9.47 % 24.29 % - 21.64 %
Profitability
CHEK DHR-PB TMO DHR IDXX A
Gross Profit Margin TTM - 60.93 % 39.46 % 60.93 % 61.8 % 52.43 %
Return on Assets TTM -4996.55 % 4.33 % 6.09 % 4.33 % 31.62 % 10.24 %
Return on Equity TTM 1299.1 % 6.99 % 13.14 % 6.99 % 69.78 % 20.62 %
Return on Capital Employed TTM 1334.03 % 6.7 % 8.41 % 6.7 % 61.76 % 14.25 %
Net Income Per EBT TTM 100 % 85.38 % 92.39 % 85.38 % 80.01 % 90.8 %
EBT Per Ebit TTM 98.47 % 82.4 % 90.83 % 82.4 % 97.36 % 97.03 %
EBIT Per Revenue TTM - 20.91 % 17.96 % 20.91 % 31.6 % 21.29 %
Cash Flow To Debt Ratio TTM -0.79 % 34.84 % 19.85 % 34.84 % 1575.85 % 46.48 %
Receivables Turnover TTM - 6.28 5.01 6.28 7.79 4.67
Payables Turnover TTM - 5.2 - 5.2 14.89 5.8
Inventory Turnover TTM - 3.86 4.97 3.86 4.35 3.22
Fixed Asset Turnover TTM - 444.19 % 421.73 % 444.19 % 575.84 % 343.45 %
Asset Turnover TTM - 29.44 % 40.38 % 29.44 % 128.44 % 54.59 %
Operating Cash Flow Per Share TTM - 9.07 20.79 9.07 14.75 5.51
Free Cash Flow Per Share TTM - 7.44 16.74 7.44 13.2 4.07
Cash Per Share TTM 4.53 % 652.48 % 2687.5 % 652.48 % 224.82 % 632.16 %
Operating Cash Flow Sales Ratio TTM - 26.12 % 17.55 % 26.12 % 27.46 % 22.44 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 81.98 % 80.49 % 81.98 % 89.45 % 73.89 %
Cash Flow Coverage Ratios TTM -0.79 % 34.84 % 19.85 % 34.84 % 1575.85 % 46.48 %
Price To Free Cash Flows Ratio TTM -9169.33 29.11 32.41 29.11 48.69 31.89
Price To Operating Cash Flows Ratio TTM -9163.21 23.88 26.11 23.88 43.69 23.52
Price Cash Flow Ratio TTM -9163.21 23.88 26.11 23.88 43.69 23.52
Income Statement (TTM)
CHEK DHR-PB TMO DHR IDXX A
Revenue $0B $24.57B $44.56B $24.57B $4.3B $6.95B
Gross Profit $-0B $14.97B $16.78B $14.97B $2.66B $3.64B
Gross Profit Ratio 0% 60.93% 37.66% 60.93% 61.8% 52.43%
EBITDA $-0.01B $6.95B $10.89B $6.95B $1.47B $1.84B
Net Income $-0.03B $3.61B $6.74B $3.61B $1.06B $1.3B
EPS Diluted -4.3 5.04 17.74 5.04 13.08 4.57
Balance Sheet (MRQ)
CHEK DHR-PB TMO DHR IDXX A
Long Term Debt $0B $18.42B $35.85B $18.42B $0.37B $3.05B
Total Liabilities $0B $30.93B $56.81B $30.93B $1.75B $5.99B
Total Equity $-0B $52.54B $53.54B $52.54B $1.61B $6.74B
Total Investments $0B $0B $0.25B $0B $0B $0.13B
Total Debt $0B $18.42B $39.39B $18.42B $0.85B $3.35B
Total Assets $0B $83.46B $110.34B $83.46B $3.35B $12.73B
Cash Flow Statement (TTM)
CHEK DHR-PB TMO DHR IDXX A
Net Income $-0.03B $3.61B $6.72B $3.61B $1.06B $0.43B
Inventory $0B $-0.06B $0B $-0.06B $0B $0.05B
Dividends Paid $0B $-0.88B $-0.64B $-0.88B $0B $-0.28B
Operating Cash Flow $-0B $6.42B $7.82B $6.42B $1.18B $1.56B
Capital Expenditure $0B $-1.16B $-1.53B $-1.16B $-0.12B $-0.41B
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 127.51
ACRS Aclaris Therapeutics, Inc. 3.695
ADVB Advanced Biomed Inc. Common Stock 0.243
AKU Akumin Inc. 0.2887
APDN Applied DNA Sciences, Inc. 5.62
AWH Aspira Women's Health Inc. 0.082
BDSX Biodesix, Inc. 10
BIAF bioAffinity Technologies, Inc. 0.9025
BIAFW bioAffinity Technologies, Inc. 0.25
BIOC Biocept, Inc. 0.4349
BLLN BillionToOne, Inc. 92.59
BNGO Bionano Genomics, Inc. 1.15
BNGOW BioNano Genomics, Inc. WT EXP 082123 0.0036
BNR Burning Rock Biotech Limited 30.91
CDNA CareDx, Inc 20.2
CEMI Chembio Diagnostics, Inc. 0.455
CNTG Centogene N.V. 0.325
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 185.74
CSTL Castle Biosciences, Inc. 32.25
Unlock